Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Human immunodeficiency virus 1 | Integrase | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Trypanosoma brucei | RNA helicase, putative | Get druggable targets OG5_139608 | All targets in OG5_139608 |
Trypanosoma congolense | RNA helicase, putative | Get druggable targets OG5_139608 | All targets in OG5_139608 |
Plasmodium yoelii | integrase-related | Get druggable targets OG5_139608 | All targets in OG5_139608 |
Schistosoma mansoni | hypothetical protein | Get druggable targets OG5_139608 | All targets in OG5_139608 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium tuberculosis | Phosphotyrosine protein phosphatase PtpA (protein-tyrosine-phosphatase) (PTPase) (LMW phosphatase) | 0.0129 | 0.4545 | 0.5 |
Brugia malayi | hypothetical protein | 0.015 | 0.5564 | 0.5564 |
Trichomonas vaginalis | low molecular weight protein tyrosine phosphatase, putative | 0.0186 | 0.7249 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0125 | 0.4375 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0057 | 0.1182 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.007 | 0.1767 | 0.4038 |
Brugia malayi | Low molecular weight phosphotyrosine protein phosphatase containing protein | 0.0186 | 0.7249 | 0.7249 |
Loa Loa (eye worm) | hypothetical protein | 0.0102 | 0.3289 | 0.3289 |
Loa Loa (eye worm) | phosphotyrosine protein phosphatase | 0.0186 | 0.7249 | 0.7249 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0032 | 0 | 0.5 |
Trichomonas vaginalis | low molecular weight protein-tyrosine-phosphatase, putative | 0.0186 | 0.7249 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0057 | 0.1182 | 0.5 |
Trypanosoma brucei | RNA helicase, putative | 0.0125 | 0.4375 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0057 | 0.1182 | 0.5 |
Trichomonas vaginalis | low molecular weight protein tyrosine phosphatase, putative | 0.0186 | 0.7249 | 1 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0032 | 0 | 0.5 |
Mycobacterium ulcerans | phosphotyrosine protein phosphatase PtpA | 0.0186 | 0.7249 | 0.5 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0244 | 1 | 1 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0032 | 0 | 0.5 |
Trichomonas vaginalis | low molecular weight protein tyrosine phosphatase, putative | 0.0186 | 0.7249 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.015 | 0.5564 | 0.5564 |
Giardia lamblia | Low molecular weight protein-tyrosine-phosphatase | 0.0186 | 0.7249 | 0.5 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0102 | 0.3289 | 0.3289 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0244 | 1 | 1 |
Trichomonas vaginalis | low molecular weight protein-tyrosine-phosphatase, putative | 0.0186 | 0.7249 | 1 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0102 | 0.3289 | 0.3289 |
Echinococcus granulosus | GPCR family 2 | 0.0032 | 0 | 0.5 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.007 | 0.1767 | 0.1767 |
Trichomonas vaginalis | low molecular weight protein-tyrosine-phosphatase, putative | 0.0186 | 0.7249 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.007 | 0.1767 | 0.1767 |
Echinococcus multilocularis | GPCR, family 2 | 0.0032 | 0 | 0.5 |
Onchocerca volvulus | 0.0186 | 0.7249 | 1 | |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0032 | 0 | 0.5 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0102 | 0.3289 | 0.3289 |
Entamoeba histolytica | protein tyrosine phosphatase, putative | 0.0186 | 0.7249 | 0.5 |
Entamoeba histolytica | protein tyrosine phosphatase, putative | 0.0186 | 0.7249 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.